Source: http://www.asmscience.org/content/book/10.1128/9781555816940.chap5
Timestamp: 2019-04-25 23:53:38+00:00

Document:
Well before Louis Pasteur&apos;s success with the vaccination of Joseph Meister, rabies evoked strong sentiments in virtually all segments of the human population, providing rich fodder for legend and literature. In 1995, rabies in foxes and cats was still significant, with cats rather than dogs now leading as the most common rabid domestic animals. The gradual transition in animal rabies has resulted in major epidemiologic changes in human rabies, with concomitant implications for postexposure prophylaxis (PEP) recommendations. Rather, human attraction to the recreational and economic benefits provided by wildlife has contributed to the reemergence of rabies as a major zoonosis. Rabies PEP consists of wound care, active vaccination, and passive immunoglobulin administration. The foundation of human rabies prevention is based on reliable identification of an exposure and the institution of prompt, appropriate PEP. The example provided by raccoon rabies is perhaps the most striking translocation story in recent years. In 1977, when the index case occurred near the Virginia-West Virginia border, one of the most intensive outbreaks of wildlife rabies in the United States began. Given the multispecies complexity of rabies and the considerable size of affected geographic areas, together with the opportunity for translocation of infected furbearers, it is unclear if traditional preventive strategies can lessen its burden on the public health infrastructure.
Rabies in the United States, 1955 versus 1995: contrasting trends in dogs, raccoons and other species.
Human rabies in the United States from 1983 to 1989 and from 1990 to 1996.
Raccoon rabies in the United States, 1947 to 1996.
Rabies in Texas, 1986 to 1995: trends in dogs and coyotes.
1. Adle-Biassette, H.,, H. Bourhy,, M. Gisselbrecht,, F. Chretien,, L., Wingertsmann,, M. Baudrimont,, Y. Rotivel,, B. Godeau,, and F. Gray. 1996. Rabies encephalitis in a patient with AIDS: a clinic-pathological study. Acta Neuropathol. 92: 425– 420.
2. Allworth, A.,, K. Murray,, and J. Morgan. 1996. A human case of encephalitis due to a Iyssavirus recently identified in fruit bats. Communicable Dis. Intel. 20: 504.
3. Alvarez, L.,, M. Cashat,, E. Arellano,, and G. M. Baer. 1996. A new phenomenon in rabies: partial recovery in children treated promptly with potent vaccine, p. 78. In Abstracts of the VII Annual International Meeting on Advances towards Rabies Control in the Americas, Atlanta, Ga.
4. Anderson, L. J.,, K. G. Nicholson,, R. V. Tauxe,, and W. G. Winkler. 1984. Human rabies in the United States, 1960-1979: epidemiology. diagnosis. and prevention. Intern. Med. 100: 728– 735.
5. Aubert, M. F.,, E. Masson,, M. Artois,, and J. Barrat. 1994. Oral wildlife rabies vaccination field trials in Europe, with recent emphasis on France. Curr. Top. Microbiol. Immunol. 187: 219– 243.
6. Baer, G. M. 1988. Oral rabies vaccination: an overview. Rev. Infect. Dis. 10( Suppl. 4): S644– S648.
7. Baer, G. M.,, M. K. Abelseth,, and J. G. Debbie. 1971. Oral vaccination of foxes against rabies. Am. J. Epidemiol. 93: 487– 490.
8. Bigler, L. L.,, and D. H. Lein. 1996. Oral rabies vaccination of raccoons in the St. Lawrence. Niagara, and Erie regions of New York State. p. 27. In Abstracts of the VII Annual International Meeting on Advances towards Rabies Colllroi in the Americas, Atlanta, Ga.
9. Bourhy, H.,, B. Kissy,, M. Lafon,, D. Sacramento,, and N. Tordo. 1992. Antigenic and molecular characterization of bat rabies virus in Europe. J. Clin. Microbiol. 30: 2419– 2426.
10. Canton, S. B.,, R. D. Clover,, and R. F. Thompson. 1994. A decision-analytic approach to postexposure rabies prophylaxis. Public Health Briefs 84: 1144– 1148.
11. Centers for Disease Control. 1983. Human rabies—Michigan. Morbid. Mortal. Weekly Rep. 32: 159– 160.
12. Centers for Disease Control. 1984. Human rabies—Pennsylvania. Morbid. Mortal. Weekly Rep. 33: 633– 635.
13. Centers for Disease Control. 1991. Human rabies—Texas, 1990. Morbid. Mortal. Weekly Rep. 40: 132– 133.
14. Centers for Disease Control. 1991. Human rabies—Texas. Arkansas. Georgia, 1991. Morbid. Mortal. Weekly Rep. 40: 765– 769.
15. Centers for Disease Control. 1991. Rabies prevention—United States, 1991. Recommendations of the Immunization Practices Advisory Committee (ACIP). Morbid. Mortal. Weekly Rep. 40(RR-3): 1– 19.
16. Centers for Disease Control and Prevention. 1994. Human rabies—New York. 1993 . Morbid. Mortal. Weekly Rep. 42: 799,805-806.
17. Centers for Disease Control and Prevention. 1995. Human rabies—Alabama, Tennessee. Texas. 1994. Morbid. Mortal. Weekly Rep. 44: 269– 272.
18. Centers for Disease Control and Prevention. 1995. Human rabies—California. 1995. Morbid. Mortal. Weekly Rep. 45: 353– 356.
19. Centers for Disease Control and Prevention. 1995. Human rabies—Washington. 1995. Morbid. Mortal. Weekly Rep. 44: 625– 627.
20. Centers for Disease Control and Prevention. 1995. Human rabies—West Virginia. 1994. Morbid. Mortal. Weekly Rep. 44: 86–87., 93.
21. Centers for Disease Control and Prevention. 1995. Mass treatment of humans exposed to Rabies—New Hampshire. 1994. Morbid. Mortal. Weekly Rep. 44: 484– 486.
22. Centers for Disease Control and Prevention. 1995. Translocation of coyote rabies—Florida, 1994. Morbid. Mortal. Weekly Rep. 44: 580– 581, 587.
23. Centers for Disease Control and Prevention. 1996. Human rabies—Connecticut, 1995. Morbid. Mortal. Weekly Rep. 45: 207– 209.
24. Centers for Disease Control and Prevention. 1996. Rabies postexposure prophylaxis—Connecticut. 1990-1994. Morbid. Mortal. Weekly Rep. 45: 232– 234.
25. Centers for Disease Control and Prevention. 1997. Compendium of animal rabies control. 1997. Morbid. Mortal. Weekly Rep. 46(RR-4): 1– 9.
26. Centers for Disease Control and Prevention. 1997. Human rabies—New Hampshire, 1996, Morbid. Mortal. Weekly Rep. 46: 267– 270.
27. Chariton, K. M. 1994. The pathogenesis of rabies and other lyssaviral infections: recent studies. Curr. Top. Microbial. Immunol. 187: 95– 120.
28. Childs, J. E.,, L. Colby,, J. W. Krebs,, T. Strine,, M. Feller,, D. Noah,, C. Drenzek,, J. S. Smith,, and C. E. Rupprecht. 1997. Surveillance and spatiotemporal associations of rabies in rodents and lagomorphs in the United States, 1990-1994. J. Wildl. Dis. 33: 20– 27.
29. Childs, J. E .,, C. V. Trimarchi,, and J. W. Krebs. 1994. The epidemiology of bat rabies in New York State, 1988-92. Epidemiol. Infect. 113: 501– 511.
30. Clark, K. A.,, S. U. Neill,, J. S. Smith,, P. J. Wilson,, V. W. Whadford,, and G. W. McKirahan. 1994. Epizootic canine rabies transmitted by coyotes in south Texas. J. Am. Vet. Med. Assoc. 204: 536– 540.
31. Dato, V. M.,, and F. E. Sorhage. 1993. Guide to pre- and postexposure rabies treatment. N. J. Med. 90: 751– 754.
32. Dato, V. M.,, F. E. Sorhage,, and K. C. Spitalny. 1995. Postexposure rabies prophylaxis. I. Experience with a computerized algorithm. Am. J. Public Health 86: 1020– 1021.
33. Davidson, W. R.,, M. J. Appel,, G. L. Doster,, O. E. Baker,, and J. F. Brown. 1992. Diseases and parasites of red foxes, gray foxes, and coyotes from commercial sources selling to fox-chasing enclosures. J. Wildl. Dis. 28: 581– 589.
34. Debbie, J. G., 1991. Rabies control of terrestrial wildlife by population reduction, p. 477– 484. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, Fla.
35. Foggin, C. M. 1983. Mokola virus infection in cats and a dog in Zimbabwe. Vet. Rec. 113: 115.
36. Fraser, G. C.,, P. T. Hooper,, R. A. Lunt,, A. R. Gould,, L. J. Gleeson,, A. D. Hyatt,, G. M. Russell,, and J. A. Kattenbelt. 1996. Encephalitis caused by a lyssavirus in fruit bats in Australia. Emerg. Infect. Dis. 2: 327– 331.
37. Geller, R. J.,, E. M. Wisniewski,, S. E. Gorman,, G. P. Lopez,, and K. E. Toomey. 1996. R accoon Rabies—the urban challenge, p. 39. In Abstracts of the VII Annual International Meeting on Advances towards Rabies Control in the Americas, Atlanta, Ga.
38. Hanlon, C. A.,, J. R. Buchanan,, E. Nelson,, H. S. Niu,, D. Diehl,, and C. E. Rupprecht. 1993. A vaccinia-vectored rabies vaccine field trial: ante- and post-mortem biomarkers. Rev. Sci. Tech. Off. Int. Epizooties 12: 99– 107.
39. Hanlon, C. A.,, A. Willsey,, B. Laniewicz,, C. V. Trimarchi,, and C. E. Rupprecht. 1996. New York. State oral wildlife rabies vaccination: first evaluation for enzootic raccoon rabies control. p. 26. In Abstracts of the VII Annual International Meeting on Advances towards Rabies Control in the Americas, Atlanta, Ga.
40. Hanlon, C. L.,, D. E. Hayes,, A. N. Hamir,, D. E. Snyder,, S. Jenkins,, C. P. Hable,, and C. E. Rupprecht. 1989. Proposed field evaluation of a rabies recombinant vaccine for raccoons ( Procyon lotor): site selection, target species characteristics, and placebo baiting trials. J. Wildl. Dis. 25: 555– 567.
41. Harrigan, R. A.,, and F. H. Kauffman. 1996. Postexposure rabies prophylaxis in an urban emergency department. J. Emerg. Med. 14: 287– 292.
42. Held, J. R.,, E. S. Tierkel,, and J. H. Steele. 1967. Rabies in man and animals in the United States:1946-1965. Public Health Rep. 82: 1009– 1018.
43. Hemachuda, T. 1994. Human rabies: clinical aspects, pathogenesis, and potential therapy. Curr. Top. Microbiol. Immunol. 187: 121– 143.
44. Hitchcock, J. C., 1994. The European ferret. Mustela putorius (family Mustelidae). its public health, wildlife. and agricultural significance. p. 207– 212. In W. S. Halverson, and A. C. Crabb (ed)., Proceedings of the 16th Vertebrate Pest Conference. University of California, Davis.
45. Kappeler, A.,, U. Breitenmoser,, R. Zanoni,, and A. I. Wandeler. 1994. Rabies on both sides of the border—an update on recent developments in Switzerland, p. 19. In Abstracts of the V Annual International Meeting Rabies in the Americas: Coping with Invading Rabies Epizootics. Niagara Falls, Ontario, Canada.
46. Kieny, M. P.,, R. Lathe,, R. Drillien,, D. Spehner,, S. Skory,, D. Schmitt,, T. J. Wiktor,, H. Koprowski,, and J. P. Lecocq. 1984. Expression of the rabies virus glycoprotein from a recombinant vaccinia virus. Nature 312: 163– l66.
47. King, A. A.,, C. D. Meredith,, and G. R. Thompson. 1994. The biology of South African Iyssavirus variants. Curr. Top. Microbiol. Immunol. 187: 267– 296.
48. Krebs, J. W.,, T. W. Strine,, J. S. Smith,, D. L. Noah,, C. E. Rupprecht,, and J. E. Childs. 1996. Rabies surveillance in the United States during 1995. J. Am. Vet. Med. Assoc. 209: 2031– 2044.
49. Krebs, J. W.,, T. W. Strine,, J. S. Smith,, C. E. Rupprecht,, and J. E. Childs. 1994. Rabies surveillance in the United States during 1993. J. Am. Vet. Med. Assoc. 205: 1695– 1709.
50. Llorens, S. A.,, and D. Neuhauser. 1995. Postexposure rabies prophylaxis. 2. Expanding the treatment model. Am. J. Public Health 86: 1021.
51. McLean, R. G., 1975. Raccoon rabies, p. 53– 77. In G. M. Baer (ed.), The Natural History of Rabies, vol. 2. Academic Press. New York. N.Y..
52. Meltzer, M. I. 1996. Assessing the cost and benefits of an oral vaccine for raccoon rabies: a possible model. Emerg. Infect. Dis. 2: 343– 349.
53. Mitchell, K. D., and J. P. Heilman. 1996. Raccoon rabies—the urban challenge. p. 30. In Abstracts of the VII Annual International Meeting on Advances towards Rabies Control in the Americas. Atlanta, Ga..
54. Morimoto, K.,, M. Patel,, S. Corisdeo,, D. C. Hooper,, Z. F. Fu,, C. E. Rupprecht,, H. Koprowski,, and B. Dietzschold. 1996. Characterization of a unique variant of bat rabies responsible for newly emerging human cases in North America. Proc. Natl. Acad. Sci. USA 93: 5653– 5658.
55. Murray, K.,, R. Rogers,, L. Selvay,, P. Selleck,, A. Hyatt,, A. Gould,, L. Gleeson,, P. Hooper,, and H. Westbury. 1995 . A novel morbillivirus pneumonia of horses and its transmission to humans. Emerg. Infect. Dis. 1: 31– 33.
56. Nettles, V. F.,, J. H. Shaddock,, R. K. Sikes,, and C. R. Reyes. 1979. Rabies in translocated raccoons. Am. J. Public Health 69: 170– 179.
57. Noah, D. L.,, G. Smith,, J. C. Gotthardt,, J. W. Krebs,, D. Green,, and J. E. Childs. 1996. Mass human exposure to rabies in New Hampshire: exposures, treatment, and cost. Am. J. Public Health 86: 1149– 1151.
58. Robbins, A. H.,, M. Borden,, M. Niezgoda,, L. Feinstein,, B. S. Windmiller,, M. W. McGuill,, C. E. Rupprecht,, and S. L. Rowell, 1996. Oral rabies vaccination of raccoons ( Procyon lotor) on the Cape Cod Isthmus, Massachuseus. p. 28. In Abslracts of the VII Annual International Meeting on Advances towards Rabies Control in the Americas. Atlanta, Ga..
59. Roscoe, D.,, W. Holste,, M. Niezgoda,, and C. E. Rupprecht. 1994. Efficacy of the V-RG oral rabies vaccine in blocking epizootic raccoon rabies. p. 15. In Abstracts of the V Annual International Meeting Rabies in the Americas: Coping with Invading Rabies Epizootics, Niagara Falls, Ontario, Canada.
60. Roscoe, D. E.,, F. E. Sorhage,, W. C. Holste,, K. Kirk-Prugh,, C. Campbell,, and C. E. Rupprecht. 1996. Vaccinia-rabies glycoprotein (V-RG) vaccine field trial. NJ 1992-1995. p. 29. In Abstracts of the VII Annual International Meeting on Advances towards Rabies Control in the Americas. Atlanta, Ga..
61. Rupprecht, C. E.,, K. M. Charlton,, M. Artois,, G. A. Casey,, W. A. Webster,, J. B. Campbell,, K. F. Lawson,, and L. G. Schneider. 1990. [neffectiveness and comparative pathogenicity of attenuated rabies virus vaccine for the striped skunk ( Mephitis mephitis). J. Wildl. Dis. 26: 99– 102.
62. Rupprecht, C. E.,, B. Dietzschold,, J. H. Cox,, and L. G. Schneider. 1989. Oral vaccination of raccoons ( Procyon lotor) with an attenuated (SAD-B19) rabies virus vaccine. J. Wildl. Dis. 25: 548– 554.
63. Rupprecht, C. E.,, B. Dietzschold,, H. Koprowski,, and D. H. Jobnston,. 1987. Development of an oral wildlife rabies vaccine: immunization of raccoons by a vaccinia-rabies glycoprotein recombinant virus and preliminary field baiting trials, p. 389– 392. In R. M. Chanock (ed.), Vaccines '87. Cold Spring Harbor Laboratory, Cold Spring Harbor. N. Y..
64. Rupprecht, C. E.,, A. N. Hamir,, D. H. Johnston,, and H. Koprowski. 1988. Efficacy of vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons ( Procyon lotor). Rev. Infect. Dis. 10( Suppl. 4): S803– S809.
65. Rupprecht, C. E.,, C. A. Hanlon,, L. B. Cummins,, and H. Koprowski. 1992. Primate responses to a vaccinia-rabies glycoprotein recombinant virus vaccine. Vaccine 10: 368– 374.
66. Rupprecht, C. E.,, C. A. Hanlon,, A. Hamir,, and H. Koprowski,. 1992. Oral wildlife rabies vaccination: development of a recombinant virus vaccine, p. 439– 452. In R. A. McCabe (ed.), Transactions of the 57th North American Wildlife and Natural Resources Conference. Wildlife Management Institute, Washington. D.C..
67. Rupprecht, C. E.,, C. A. Hanlon,, M. Niezgoda,, J. R. Buchanan,, D. Diehl,, and H. Koprowski. 1993. Recombinant rabies vaccines: efficacy assessment in free-ranging animals. Onderstepoort J. Vet. Res. 60: 463– 468.
68. Rupprecht, C. E.,, and M. P. Kieny,. 1988. Development of a vaccinia-rabies glycoprotein recombinant rabies vaccine, p. 335– 364. In J, B. Campbell, and K. M. Charlton (ed.), Rabies: Developments in Veterinary Vaccines. Kluwer Academic Publishers, Boston, Mass..
69. Rupprecht, C. E.,, and J. S. Smith. 1994. Raccoon rabies: the re-emergence of an epizootic in a densely populated area. Semin. Virol. 5: 155– 164.
70. Rupprecbt, C. E.,, J. S. Smith,, M. Fekadu,, and J. E. Childs. 1995. The ascension of wildlife rabies: a cause for public health concern or intervention? Emerg. Infect. Dis. 1: 107– 114.
71. Rupprecht, C. E.,, J. S. Smith,, J. Krebs,, M. Niezgoda,, and J. E. Childs. 1996. Current issues in rabies prevention in the United States: health dilemmas. public coffers, private interests. Public Health Rep. 111: 400– 407.
72. Rupprecht, C. E.,, T. J. Wiktor,, D. H. Johnston,, A. N. Hamir,, B. Dietzschold,, W. H. Wunner,, L. T. Glickman,, and H. Koprowski. 1986. Oral immunization and protection of raccoons ( Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proc. Natl. Acad. Sci. USA 83: 7947– 7950.
73. Sasaki, D. M.,, C. R. Middleton,, T. R. Sawa,, C. C. Christensen,, and G. Y. Kobayashi. 1992. Rabid bat diagnosed in Hawaii. Hawaii Med. J. 51: 181– 185.
74. Schneider, L. G.,, J. H. Cox,, W. W. Muller,, and K. P. Hohnsbeen. 1988. Current oral rabies vaccination in Europe: an interim balance. Rev. Infect. Dis. 10( Suppl. 4): S654– S659.
75. Smith, J. S. 1996. New aspects of rabies with emphasis on epidemiology, diagnosis, and prevention of the disease in the United States. Clin. Microbiol. Rev. 9: 166– 176.
76. Smith, J. S., 1996. Rabies virus, p. 997– 1003. In P. R. Murray,, E. J. Baron,, M. A. Pfaller,, F. C. Tenover,, and R. H. Yolken (ed.), Manual of Clinical Microbiology, 6th ed. ASM Press, Washington, D.C..
77. Smith, J. S.,, D. B. Fishbein,, C. E. Rupprecht,, and K. Clark, 1991. Unexplained rabies in three immigrants in the United States. N. Engl. J. Med. 324: 205– 211.
78.Smith, J, S., L. A. Orciari, and P. A. Yager. 1995. Molecular epidemiology of rabies in the United States. Semi. Virol. 6: 387– 400.
79. Steck, F. A.,, A. Wandeler,, P. Bischel,, S. Capt,, U. Hafliger,, and L. Schneider. 1982. Oral immunization of wildlife against rabies. Comp. Immunol. Microbiol. Inject. Dis. 5: 165– 171.
80. Swanepoel, R.,, B. J, Barnard, C. D, Meredith, G. C. Bishop, G. K. Bruckner, C. M, Foggin, and O. J. Hubschle. 1993. Rabies in southern Africa. Onderstepoort J. Vet. Med. 60: 325– 346.
81. Thomas, I.,, B. Brochier,, B. Languet,, J. Blancou,, D. Peharpre,, M. P. Kieny,, P. Desmettre,, G. Chappuis,, and P. P. Pastoret. 1990. Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route. J. Gen. Virol. 71: 37– 42.
82. Uhaa, I. J.,, V. M. Dato,, F.E, Sorhage,, J. W. Beckley,, D. E. Roscoe,, R. D. Gorsky,, and D. B. Fishbein. 1992. Benefits and costs of using an orally absorbed vaccine to control rabies in raccoons. J. Am. Vet. Med. Assoc. 201: 1873– 1882.
82.a. U.S. Department of Health and Human Services, Public Health Service. 1990. Healthy People 2000: National Health Promotion and Disease Prevention Objectives. DHHS publication 91-50213. U.S. Department of Health and Human Services, Washington, D.C..
83. Wandeler, A. I., 1991. Oral immunization of wildlife, p. 485– 503. In G. M. Baer (ed.), Natural History of Rabies, 2nd ed. CRC Press, Inc., Boca Raton, Fla..
84. Wisniewski, E.,, G. Lopez,, and R. Geller. 1996. The benefits of a regional poison center offering treatment advice for animal bites. J. Toxicol. 34: 614– 615.
85.World Health Organization. 1986. Bat rabies cases in the Federal Republic of Germany. W. H. O. Rabies Bull. Eur. 10: 8– 9.
86.World Health Organization. 1992. WHO Expert Committee on Rabies. WHO Technical Report Series R24. World Health Organization, Geneva, Switzerland.
87.. World Health Organization. 1995. Oral immunization of foxes in Europe in 1994. Weekly Epidemiol. Rec. 70: 89– 91.
88. Young, P. L.,, K. Halpin,, P. W. Selleck,, H. Field,, J. L. Gravel,, M. A. Kelly,, and J. S. Mackenzie. 1996. Serologic evidence for the presence in pteropus bats of a paramyxovirus related to equine morbillivirus. Emerg. Infect. Dis. 2: 239– 240.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.